EUVIMEDEUVIMED entdecken
Open Access

Ivabradine ameliorates cardiomyopathy progression in a Duchenne muscular dystrophy model rat

Ryota Tochinai, Koichi Kimura, Takeru Saika, Wataru Fujii, Hiroyuki Morita, Koki Nakanishi, Yoshiharu Tsuru, Shin-Ichi Sekizawa, Keitaro Yamanouchi, Masayoshi Kuwahara

Experimental Animals · 2024 · 73 (2) · 145-153

DOI: 10.1538/expanim.23-0087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Animals, 2024. Verfasst von Ryota Tochinai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Pathophysiology and Animal Health, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, …. Hauptthemen laut MEDLINE: Ivabradine, Muscular Dystrophy, Duchenne, Cardiomyopathies, Disease Models, Animal. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Duchenne muscular dystrophy (DMD) is an X-linked recessive myopathy caused by dystrophin mutations. Inevitable progressive cardiomyopathy is a current leading cause of premature death although respiratory management has improved the prognosis of patients with DMD. Recent evidence shows that reducing the heart rate is expected as one of the promising strategies for heart failure treatment, but administering a sufficient dose of β-blocker for patients with DMD with tachycardia is difficult because of their low blood pressure (BP). Thus, this study aimed to clarify the role of ivabradine, which suppresses cardiac sinus node pacemakers without decreasing BP, in ameliorating cardiomyopathy progression in a rat model with DMD. A trans-oral single ivabradine administration demonstrated a declined dose-dependent heart rate without any significant BP reduction. Trans-gastric repeated administrations of 5 mg/kg of ivabradine twice a day for 3 months showed ameliorated cardiomyopathy in DMD rats based on echocardiography and histopathological observations (left ventricular dysfunction, right ventricular dysfunction, and myocardial fibrosis) as compared with vehicle administration.Our finding indicates that ivabradine is expected as another treatment choice for patients with DMD having tachycardia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IvabradineMuscular Dystrophy, DuchenneCardiomyopathiesDisease Models, AnimalDisease ProgressionHeart RateAnimalsMaleRatsRats, Sprague-DawleyTachycardia

Stichwörter der Autor:innen

dystrophin deficiencyechocardiographyhearthyperpolarization-activated cyclic nucleotide-gated (HCN) channeltachycardia

Substanzen

Ivabradine

Autor:innen und Institutionen

  • Department of Veterinary Pathophysiology and Animal Health, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.
  • Departments of Laboratory Medicine and Cardiology, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.
  • Laboratory of Biomedical Science, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.
  • Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Bunkyo-ku, Tokyo 113-8655, Japan.
  • Life Science Laboratory, Primetech Corporation, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.
  • Department of Veterinary Physiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.

Zitieren

APA

Tochinai, R., Kimura, K., Saika, T., Fujii, W., Morita, H., Nakanishi, K., Tsuru, Y., Sekizawa, S. I., Yamanouchi, K., & Kuwahara, M. (2024). Ivabradine ameliorates cardiomyopathy progression in a Duchenne muscular dystrophy model rat. Experimental Animals, 73(2), 145-153. https://doi.org/10.1538/expanim.23-0087

Vancouver

Tochinai R, Kimura K, Saika T, Fujii W, Morita H, Nakanishi K, et al. Ivabradine ameliorates cardiomyopathy progression in a Duchenne muscular dystrophy model rat. Experimental Animals. 2024;73(2):145-153. doi:10.1538/expanim.23-0087

BibTeX
@article{Tochinai2024,
  author = {Tochinai, Ryota and Kimura, Koichi and Saika, Takeru and Fujii, Wataru and Morita, Hiroyuki and Nakanishi, Koki and Tsuru, Yoshiharu and Sekizawa, Shin-Ichi and Yamanouchi, Keitaro and Kuwahara, Masayoshi},
  title = {Ivabradine ameliorates cardiomyopathy progression in a Duchenne muscular dystrophy model rat},
  journal = {Experimental Animals},
  year = {2024},
  volume = {73},
  number = {2},
  pages = {145--153},
  doi = {10.1538/expanim.23-0087}
}
Kostenlos starten →